| S. No. | Title of the project | Funding agency | Duration | Funds /sanct (Rs., Lakh) |
| 1 | PI: Possible mechanisms of attenuation of the cardioprotective and neuroprotective effect of Ischemic preconditioning | Research Initiation Grant, BITS Pilani | 2012-14 (Completed) | 2.0 Lakhs |
| 2 | PI: Exploring pharmacological potential of GSK-3β and HDAC inhibitor alone and in combination... | University Grants Commission | 2013-2015 | 6.0 Lakhs |
| 3 | PI: Exploring neuroprotective effect and molecular mechanisms of remote limb ischemic post-conditioning... | Department of Science and Tech (DST) | 2013-16 | 26.99 Lakhs |
| 4 | Co-PI: Evaluation of standardized formulation of Trigonella foenum-graecum in controlling the blood sugar... | Indian Council of Medical Research (ICMR) | 2017-2018 | 30.62 Lakhs |
| 5 | PI: Exploring the synergism of PPAR-Y agonist and HDAC inhibitor for reversal of Alzheimer | DST: Nanomision | 2017-2020 | 32.13 Lakhs |
| 6 | PI; Formulation development and determination of repeat dose chronic toxicity... | Etica Clinpharm | 2016-2017 | 2.25 Lakhs |
| 7 | PI: To study the protective effects of Herbal formulation against Myocardial Ischemia- reperfusion injury.... | Etica Clinpharm | 2016-2017 | 4.0 Lakhs |
| | On- Going Projects |
| 8 | Co-PI: Exploring the effects of polyamine and associated metabolic regulation of hypothalamic GnRH-GnIH.... | DSR-SERB | 2018-2021 | 34.35 Lakhs |
| 9 | PI: Role of Endocrine Disrupting Chemicals (ECDs) in Maternal and Child Health : Joint Research project with AIIMS | ICMR | 2018-2021 | 66.23 Lakhs |
| 10 | PI: In vitro-In Vivo study design: Evaluation of Cardio-reno Protective Effect of Herbal extract and its mol. mech (Role of NO-cGMP pathway) | Etica Clinpharm | 2017-2019 Ongoing | 9.92 Lakhs |
| 11 | PI: Pharmacological and Safety Evaluation of Ketogenic Diet.....STZ induced Alzheimer | Zeon Life Science Ltd | 2021-2022 | 13.5 Lakhs |
| 12 | PI: Exploring the mechanism(s) of gut microbiota link to Parkinson Disease..... | ICMR | 2020-2023 | 42.50 Lakhs |
| 13 | Joint-DBT Builder "Epigenetic and genome editing- Co-PI | DBT -Builder | 2021-2026 | *9.18 crores |
| 14 | Pharmacokinetic & Pharmacodynamic Evaluation..... | Zeon Life Science Ltd | 2023-2024 | 8.85 Lakhs |
| 15 | Pharmacodynamic and P,cokinetic comparative efficacy study of tablets vs liquid Polyherbal formulation | Zeon Life Science Ltd | 2022-2023 | 12.76 Lakhs |
| 16 | Preclinical Comparative Efficacy Study of Formulations ………Neuropathic Pain in Wistar Rats | Leiutis Ltd | 2023-24 | 10.03 Lakhs |